Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
Yujiro Hayashi, Kazutoshi Fujita, Satoshi Nojima, et al.
Molecular Oncology (2020) Vol. 14, Iss. 10, pp. 2375-2383
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management
Liang Cheng, Shaobo Zhang, Ming‐Sheng Wang, et al.
Human Pathology (2022) Vol. 133, pp. 56-75
Closed Access | Times Cited: 32
Urinary markers for bladder cancer diagnosis: A review of current status and future challenges
Eisuke Tomiyama, Kazutoshi Fujita, Mamoru Hashimoto, et al.
International Journal of Urology (2023) Vol. 31, Iss. 3, pp. 208-219
Open Access | Times Cited: 16
Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer
Raquel Carrasco, Mercedes Ingelmo‐Torres, Ascensión Gómez, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11732-11732
Open Access | Times Cited: 23
TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance
Tiantian Liu, Shihong Li, Chuanyou Xia, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 14
Mutational Landscape and Environmental Effects in Bladder Cancer
Takuji Hayashi, Kazutoshi Fujita, Yujiro Hayashi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6072-6072
Open Access | Times Cited: 35
The role of telomerase reverse transcriptase (TERT) promoter mutations in prognosis in bladder cancer
Song Wan, Xuan Liu, Wei Hua, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 1495-1504
Open Access | Times Cited: 24
LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder
Lu Pei, Dong Yan, Qingqing He, et al.
Cellular Oncology (2023) Vol. 46, Iss. 5, pp. 1509-1527
Open Access | Times Cited: 9
Prognostic implication of TERT promoter mutation and circulating tumor cells in muscle-invasive bladder cancer
Raquel Carrasco, Mercedes Ingelmo‐Torres, Ascensión Gómez, et al.
World Journal of Urology (2022) Vol. 40, Iss. 8, pp. 2033-2039
Open Access | Times Cited: 15
A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma
Junjie Zhang, Ran Xu, Qiang Lü, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 615-615
Open Access | Times Cited: 7
The Clinical Validity of Urinary Pellet DNA Monitoring for the Diagnosis of Recurrent Bladder Cancer
Masakazu Abé, Hayato Hiraki, Takashi Tsuyukubo, et al.
Journal of Molecular Diagnostics (2024) Vol. 26, Iss. 4, pp. 278-291
Open Access | Times Cited: 2
The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG
Qi‐Dong Xia, Jian‐Xuan Sun, Zhipeng Yao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
Yujiro Hayashi, Kazutoshi Fujita, George J. Netto, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 16
TERT Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers
Veronika Weyerer, Markus Eckstein, Pamela L. Strissel, et al.
Genes (2021) Vol. 12, Iss. 2, pp. 230-230
Open Access | Times Cited: 15
Somatic Features of Response and Relapse in Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy
Jack V. W. Bacon, David C. Müller, Elie Ritch, et al.
European Urology Oncology (2021) Vol. 5, Iss. 6, pp. 677-686
Closed Access | Times Cited: 15
Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer
C. Goux, Sophie Vacher, Anne Schnitzler, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 14
GINS1 promotes the initiation and progression of bladder cancer by activating the AKT/mTOR/c-Myc signaling pathway
Qiqi Fu, Hang Zheng, Xia Wang, et al.
Experimental Cell Research (2024) Vol. 440, Iss. 1, pp. 114125-114125
Open Access | Times Cited: 1
The RNA-binding protein CMSS1 promotes the progression of non-small cell lung cancer by regulating the telomerase protein subunit hTERT
Wei Gu, H Li, Lei Sun, et al.
Life Sciences (2024) Vol. 361, pp. 123321-123321
Closed Access | Times Cited: 1
Precursors of urinary bladder cancer: molecular alterations and biomarkers
Alexander S. Taylor, Andrés Acosta, Hikmat Al‐Ahmadie, et al.
Human Pathology (2022) Vol. 133, pp. 5-21
Closed Access | Times Cited: 7
Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer
Yujiro Hayashi, Kazutoshi Fujita, Kazuko Sakai, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Toward urinary cell-free DNA-based treatment of urothelial carcinoma: a narrative review
Yujiro Hayashi, Kazutoshi Fujita
Translational Andrology and Urology (2021) Vol. 10, Iss. 4, pp. 1865-1877
Open Access | Times Cited: 8
Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross‐sectional data
Yujiro Hayashi, Kazutoshi Fujita, Eri Banno, et al.
International Journal of Urology (2021) Vol. 28, Iss. 7, pp. 774-776
Closed Access | Times Cited: 7
The expression level of chicken telomerase reverse transcriptase in tumors induced by ALV-J is positively correlated with methylation and mutation of its promoter region
Yong Xiang, Qinxi Chen, Qingbo Li, et al.
Veterinary Research (2022) Vol. 53, Iss. 1
Open Access | Times Cited: 4
Microenvironment of Normal-Looking Tissues Adjacent to Cancer: Matters Arising
Mohamed Wishahi
Interdisciplinary cancer research (2024)
Closed Access
TERTmonitor Efficacy and Performance in Detecting Mutations by Droplet Digital PCR
Mafalda Bessa‐Gonçalves, João Brás, Tito T. Jesus, et al.
Genes (2024) Vol. 15, Iss. 11, pp. 1424-1424
Open Access
Molecular Pathogenesis: Field Cancerization and Clonal Evolution in Urothelial Cancer Initiation and Progression
David J. McConkey, Cathy Mendelsohn, Byron Lee, et al.
(2024), pp. 221-238
Closed Access
Page 1 - Next Page

Scroll to top